CXCL12 and hepatocellular carcinoma: Therefore, regulation of ERK1/2/MMP2/9 signaling pathway may be one of the mechanisms of CXCL12-CXCR4 axis or CCL21-CCR7C axis inhibition and sinoline hydrochloride synergistic anti-HCC.